SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-026474
Filing Date
2023-05-02
Accepted
2023-05-02 16:14:25
Documents
1
Period of Report
2023-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5833
  Complete submission text file 0001209191-23-026474.txt   7187
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address
Amado Rafael (Reporting) CIK: 0001662119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 23879167